Krystal Biotech, Inc. (KRYS)

276.96 +4.30 (+1.58%) USD  |  NASDAQ  |  Apr 22, 12:58
More

Krystal Biotech Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Scholar Rock Holding Corp. Upgrade
Stoke Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
TG Therapeutics, Inc. Upgrade